Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Crgdkgpdc Peptide
2. Internalizing-rgd Peptide
3. Irgd Peptide
4. N-end Cysteine Peptide Tumor-homing Peptide
1. 1392278-76-0
2. Unii-z8mxu5gh4q
3. Irgd Peptide
4. Irgd
5. Cend-1
6. Irgd-peptide
7. Z8mxu5gh4q
8. C(crgdkgpdc)c(crgdkgpdc)
9. Nsc838763
10. Nsc-838763
11. Internalized-arginylglycylaspartic Acid Cyclic Peptide
12. Q48988348
13. L-cysteine, L-cysteinyl-l-arginylglycyl-l-alpha-aspartyl-l-lysylglycyl-l-prolyl-l-alpha-aspartyl-, Cyclic (1->9)-disulfide
| Molecular Weight | 948.0 g/mol |
|---|---|
| Molecular Formula | C35H57N13O14S2 |
| XLogP3 | -11.3 |
| Hydrogen Bond Donor Count | 14 |
| Hydrogen Bond Acceptor Count | 19 |
| Rotatable Bond Count | 13 |
| Exact Mass | 947.35893589 g/mol |
| Monoisotopic Mass | 947.35893589 g/mol |
| Topological Polar Surface Area | 503 Ų |
| Heavy Atom Count | 64 |
| Formal Charge | 0 |
| Complexity | 1750 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A CEND-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CEND-1, including repackagers and relabelers. The FDA regulates CEND-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CEND-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A CEND-1 supplier is an individual or a company that provides CEND-1 active pharmaceutical ingredient (API) or CEND-1 finished formulations upon request. The CEND-1 suppliers may include CEND-1 API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CEND-1 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CEND-1 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CEND-1 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CEND-1 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CEND-1 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CEND-1 suppliers with NDC on PharmaCompass.
CEND-1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CEND-1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CEND-1 GMP manufacturer or CEND-1 GMP API supplier for your needs.
A CEND-1 CoA (Certificate of Analysis) is a formal document that attests to CEND-1's compliance with CEND-1 specifications and serves as a tool for batch-level quality control.
CEND-1 CoA mostly includes findings from lab analyses of a specific batch. For each CEND-1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CEND-1 may be tested according to a variety of international standards, such as European Pharmacopoeia (CEND-1 EP), CEND-1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CEND-1 USP).
LOOKING FOR A SUPPLIER?
